HDFC Life Insurance Company Ltd
HDFCLIFE NSE
HDFC Life Insurance Company Ltd
Insurance F&ONSE: HDFCLIFE BSE: 540777 Life Insurance
Key Fundamentals
LargecapLife InsuranceInsuranceMarket Cap
1.2L Cr
Volatility
Moderate
P/E Ratio
58.89
EBITDA
₹2,438 Cr
Return on Equity
10.77%
Debt to Equity
0.17
Book Value
₹90.04
EPS
₹7.61
52W High
₹815
52W Low
₹530.5
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view HDFC Life Insurance Company Ltd insights
36 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 25.3%
Weaknesses
5- Stock is trading at 5.98 times its book value
- The company has delivered a poor sales growth of 6.81% over past five years.
- Tax rate seems low
- Company has a low return on equity of 11.1% over last 3 years.
- Earnings include an other income of Rs.931 Cr.
Growth Rate
Revenue Growth
3.05% ↗
Net Income Growth
5.61% ↘
Cash Flow Change
45.06% ↗
ROE
-3.93% ↘
ROCE
-1.67% ↘
EBITDA Margin (Avg.)
56.77% ↗
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 5d agoAI opinion · based on fundamentals
Risk high
HDFC Life Insurance trades at a market cap of ₹1,15,990 Cr with a PE of 59x and PB of 5.95x, reflecting premium valuations. The company has delivered 12% compounded profit growth over 3 years but sales growth has moderated to 4% TTM, while ROE remains at 11% over the last 3 years.
Bull Case 7
- 3-year compounded profit growth of 12% demonstrates consistent earnings expansion
- 10-year compounded sales growth of 19% reflects strong long-term business scaling in underpenetrated Indian insurance market
- Healthy dividend payout ratio of 25.3% indicates shareholder-friendly capital allocation
- Market cap of ₹1,15,990 Cr positions it as one of India's largest private life insurers with scale advantages
- 3-year compounded sales growth of 12% outpaces the 5-year CAGR of 7%, suggesting recent acceleration before TTM slowdown
- 10-year ROE average of 14% shows the business has historically generated reasonable returns on equity
- 5-year compounded profit growth of 7% maintained through COVID disruptions demonstrates business resilience
Bear Case 8
- PE ratio of 59x is significantly elevated relative to earnings growth of 5% TTM, implying stretched valuations
- Stock price has declined 31% over the past 1 year, indicating significant negative momentum and market re-rating
- Price-to-book of 5.95x is expensive for a company generating only 11% ROE over 3 years
- TTM sales growth has decelerated sharply to just 4% compared to 12% over 3 years
- ROE has declined from a 10-year average of 14% to 11% over the last 3 years, signaling deteriorating capital efficiency
- Other income of ₹931 Cr included in earnings raises questions about core operating profit quality
- 5-year stock CAGR of -4% shows the stock has destroyed value for medium-term investors despite profit growth
- Dividend yield of only 0.39% offers minimal income cushion given the valuation premium
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 7h ago Positives 3
- Q1FY27 net profit up 12% Jul 22
Net profit rose 12% to ₹611.42 crore in Q1FY27, with total premium growing 15% to ₹17,166 crore and VNB up 9% to ₹879 crore.
- Healthy solvency and dividend Jul 22
Solvency ratio stood at 185% with a recommended final dividend of ₹2.10 per share; preferential allotment to HDFC Bank also completed.
- Active investor engagement in Aug Aug 04
Company participating in Emkay, Motilal Oswal, and Morgan Stanley investor events in August 2026, signalling proactive institutional outreach.
Neutral 1
- ₹80 crore block trades on NSE Aug 05
Two block trades totalling ~₹80.65 crore (~1.49 million shares) executed at ₹539.85–₹544.65 per share, indicating institutional secondary market activity.
TL;DR: HDFC Life delivered solid Q1FY27 results with double-digit profit and premium growth, supported by a comfortable solvency margin. No material headwinds emerged in recent news. Block trade activity suggests steady institutional interest. The trend appears stable with growth momentum intact heading into mid-FY27.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23,371 | 23,142 | 26,927 | 28,041 | 26,934 | 28,497 | 17,300 | 24,191 | 29,463 | 20,651 | 29,428 | 19,890 | 33,759 |
| Expenses | 23,045 | 23,557 | 26,663 | 27,766 | 26,623 | 28,807 | 16,852 | 23,814 | 29,024 | 20,336 | 29,157 | 19,782 | 33,253 |
| Operating Profit | 326 | -415 | 264 | 275 | 311 | -310 | 448 | 377 | 439 | 315 | 271 | 108 | 506 |
| OPM % | 1.4% | -1.8% | 1% | 1% | 1.2% | -1.1% | 2.6% | 1.6% | 1.5% | 1.5% | 0.9% | 0.6% | 1.5% |
| Other Income | 114 | 136 | 103 | 174 | 90 | 279 | -29 | 124 | 164 | 157 | 174 | 428 | 171 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 440 | -279 | 367 | 450 | 401 | -30 | 419 | 500 | 604 | 471 | 445 | 537 | 677 |
| Tax % | 5% | -235% | 0% | 8% | -20% | -1541% | -1% | 5% | 9% | 5% | 6% | 7% | 10% |
| Net Profit | 417 | 378 | 368 | 412 | 479 | 435 | 421 | 475 | 548 | 448 | 418 | 497 | 611 |
| EPS in Rs | 1.94 | 1.76 | 1.71 | 1.91 | 2.23 | 2.02 | 1.96 | 2.21 | 2.54 | 2.08 | 1.94 | 2.31 | 2.81 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27,215 | 18,141 | 30,647 | 32,260 | 38,855 | 29,380 | 71,528 | 67,126 | 70,207 | 1,01,482 | 96,922 | 99,432 | 1,03,727 |
| Expenses | 26,341 | 17,187 | 29,674 | 31,186 | 37,640 | 28,239 | 70,294 | 66,348 | 70,127 | 1,00,836 | 95,894 | 97,679 | 1,02,527 |
| Operating Profit | 874 | 953 | 972 | 1,074 | 1,215 | 1,141 | 1,235 | 778 | 80 | 646 | 1,028 | 1,753 | 1,200 |
| OPM % | 3.2% | 5% | 3.2% | 3.3% | 3.1% | 3.9% | 1.7% | 1.2% | 0.1% | 0.6% | 1.1% | 1.8% | 1.2% |
| Other Income | 79 | 108 | 139 | 282 | 136 | 369 | 445 | 766 | 1,437 | 410 | 366 | 465 | 931 |
| Interest | -14 | 8 | 9 | 11 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 43 | 45 | 41 | 44 | 45 | 47 | 51 | 56 | 76 | 79 | 104 | 161 | 0 |
| PBT | 924 | 1,008 | 1,061 | 1,300 | 1,291 | 1,463 | 1,629 | 1,487 | 1,441 | 977 | 1,290 | 2,057 | 2,130 |
| Tax % | 15% | 19% | 16% | 15% | 1% | 11% | 16% | 11% | 5% | -61% | -40% | 7% | — |
| Net Profit | 786 | 817 | 887 | 1,107 | 1,278 | 1,297 | 1,361 | 1,327 | 1,368 | 1,574 | 1,811 | 1,912 | 1,975 |
| EPS in Rs | 3.94 | 4.09 | 4.44 | 5.5 | 6.33 | 6.43 | 6.73 | 6.28 | 6.37 | 7.32 | 8.41 | 8.86 | 9.14 |
| Div. Payout % | 18% | 22% | 25% | 25% | 26% | 0% | 30% | 27% | 30% | 27% | 25% | 24% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,995 | 1,995 | 1,998 | 2,012 | 2,017 | 2,019 | 2,021 | 2,113 | 2,149 | 2,151 | 2,153 | 2,158 |
| Reserves | 546 | 1,108 | 1,828 | 2,693 | 3,625 | 4,788 | 6,619 | 13,501 | 10,844 | 12,515 | 14,002 | 15,592 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 600 | 600 | 950 | 950 | 2,950 | 3,099 |
| Other Liabilities | 66,767 | 73,441 | 91,270 | 1,05,778 | 1,24,378 | 1,25,417 | 1,70,415 | 2,14,521 | 2,34,126 | 2,87,071 | 3,30,307 | 3,69,654 |
| Total Liabilities | 69,309 | 76,544 | 95,097 | 1,10,483 | 1,30,020 | 1,32,224 | 1,79,655 | 2,30,734 | 2,48,069 | 3,02,687 | 3,49,412 | 3,90,502 |
| Fixed Assets | 346 | 335 | 337 | 336 | 370 | 322 | 585 | 6,605 | 997 | 1,549 | 2,143 | 2,716 |
| CWIP | 6 | 12 | 16 | 5 | 10 | 8 | 14 | 20 | 31 | 28 | 109 | 139 |
| Investments | 67,024 | 74,144 | 91,723 | 1,06,590 | 1,24,958 | 1,27,256 | 1,73,564 | 2,16,551 | 2,38,197 | 2,91,128 | 3,34,756 | 3,73,340 |
| Other Assets | 1,932 | 2,053 | 3,020 | 3,551 | 4,682 | 4,637 | 5,493 | 7,559 | 8,844 | 9,982 | 12,404 | 14,308 |
| Total Assets | 69,309 | 76,544 | 95,097 | 1,10,483 | 1,30,020 | 1,32,224 | 1,79,655 | 2,30,734 | 2,48,069 | 3,02,687 | 3,49,412 | 3,90,502 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 4,459 | 5,687 | 6,230 | 6,739 | 9,868 | 7,388 | 9,703 | 5,943 | 6,883 | 10,721 | 15,597 | 22,625 |
| Investing | -3,514 | -3,962 | -5,177 | -4,421 | -10,182 | -7,789 | -8,952 | -801 | -10,071 | -13,622 | -13,633 | -23,849 |
| Financing | -168 | -212 | -236 | -196 | -337 | 38 | 678 | -238 | 1,985 | -403 | 1,607 | -275 |
| Net Cash Flow | 777 | 1,513 | 817 | 2,122 | -651 | -364 | 1,429 | 4,904 | -1,203 | -3,304 | 3,572 | -1,499 |
| Free Cash Flow | 4,352 | 5,654 | 6,183 | 6,706 | 9,825 | 7,351 | 9,643 | 5,887 | 6,797 | 10,587 | 15,300 | 22,341 |
| CFO/OP | 510 | 597 | 641 | 627 | 813 | 672 | 806 | 789 | 9,190 | 1,444 | 1,543 | 1,302 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -11 | -27 | -20 | -25 | -16 | -17 | -13 | -11 | -12 | -8 | -6 | -6 |
| ROCE % | 41% | 36% | 31% | 31% | 23% | 24% | 20% | 12% | 10% | 5% | 7% | 10% |
Documents
2
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Update On Preferential
Issue Of Equity Shares To HDFC Bank Limited
23 Apr - Updated preferential issue of 1,45,23,906 shares to HDFC Bank; post-issue stake rises to 50.27%. 23 Apr - Updated preferential issue of 1,45,23,906 shares to HDFC Bank; post-issue stake rises to 50.27%.
3
Re-Appointment Of Ms Vibha Padalkar As Managing Director & Chief Executive Officer
21 Apr - Board approved Vibha Padalkar’s reappointment as MD & CEO for five years from September 12, 2026. 21 Apr - Board approved Vibha Padalkar’s reappointment as MD & CEO for five years from September 12, 2026.
4
Grant Of Stock Options Under Employee Stock Option Scheme
21 Apr - HDFC Life approved 8,70,471 ESOP 2025 and 32,372 ESOP 2022 options at Rs. 609.75 each. 21 Apr - HDFC Life approved 8,70,471 ESOP 2025 and 32,372 ESOP 2022 options at Rs. 609.75 each.
Frequently Asked Questions about HDFC Life Insurance Company Ltd
What does HDFC Life Insurance Company Ltd do?
HDFC Life Insurance Company is engaged in carrying on the business of life insurance. The Company offers a range of individual and group insurance solutions. The portfolio comprises of various insurance and investment products such as Protection, Pension, Savings,(Source : 202003 Annual Report Pa...
Where is HDFC Life Insurance Company Ltd (HDFCLIFE) listed?
HDFC Life Insurance Company Ltd is listed on the Indian stock exchanges. It is listed on NSE: HDFCLIFE and BSE: 540777. You can view its live share price, financials, and ratios on Tapetide.
Which sector does HDFC Life Insurance Company Ltd belong to?
HDFC Life Insurance Company Ltd operates in the Insurance sector within the Life Insurance industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of HDFC Life Insurance Company Ltd?
HDFC Life Insurance Company Ltd has a market capitalisation of approximately ₹116550.94 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of HDFC Life Insurance Company Ltd?
The Price-to-Earnings (PE) ratio of HDFC Life Insurance Company Ltd is 58.89. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of HDFC Life Insurance Company Ltd?
Over the past 52 weeks, HDFC Life Insurance Company Ltd has traded between a low of ₹530.5 and a high of ₹815. This range helps investors understand the stock's price volatility and recent trading levels.
Does HDFC Life Insurance Company Ltd pay dividends?
Yes, HDFC Life Insurance Company Ltd has a dividend yield of 0.39%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of HDFC Life Insurance Company Ltd?
HDFC Life Insurance Company Ltd has a Return on Equity (ROE) of 10.77%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research HDFC Life Insurance Company Ltd on Tapetide?
On Tapetide, you can view HDFC Life Insurance Company Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
HDFC Life Insurance Company is engaged in carrying on the business of life insurance. The Company offers a range of individual and group insurance solutions. The portfolio comprises of various insurance and investment products such as Protection, Pension, Savings,(Source : 202003 Annual Report Page No: 175)
Website hdfclife.com
CEO Ms. Vibha U. Padalkar
Employees 38,470
Listed 2017-11-17
Face Value ₹ 10
Issued Size 2,15,76,15,850